Ropivacaine and Fentanyl for Labor Epidural Initiation

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07076368
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Labor Analgesia
  • Labor and Delivery
  • Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ropivacaine + Fentanyl — DRUG
    A standard epidural admixture - 0.1% Ropivacaine + 2 mcg/ml fentanyl - will be used.

Study Details

This study is being done to determine the most effective dose of medicine to use to initially provide effective pain relief within the first 30 minutes of receiving an epidural for pain labor during labor. The study team will also study any side effects related to the epidural medication and patients' satisfaction with the quality of pain relief after receiving the epidural.

Key Dates

Start date
Oct 24, 2025
Status verified
Jan 2026
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Observational Cohort
    Patients with singleton vertex pregnancies in active labor (spontaneous or after induction of labor), with a cervical dilatation between 1 and 7cm who are requesting neuraxial labor analgesia, Age =\>18 yrs

Primary Outcome Measure

Numerical Pain score [ Time Frame: 30 mins post-intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94158
Alexander Butwick
[email protected]
415-514-3757

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies